Biotech Stocks Show Promise Amidst Recent Market Challenges

Biotech industry offers potential growth opportunities, with stocks like Viking Therapeutics, Moderna, and CRISPR Therapeutics projected to surge significantly within the next year. Investors are eyeing these growth prospects for long-term returns.

Date: 28-02-2025

AI Rating: 7

Potential for Growth in Biotech Stocks

The report discusses the current landscape for biotech stocks and highlights three companies: Viking Therapeutics, Moderna, and CRISPR Therapeutics, which are positioned for significant growth. Analysts predict that Viking Therapeutics could surge 250% within the next 12 months. The company is developing VK2735, a potential drug in the weight loss market, which could carve its niche in a projected $100 billion market.

Moderna, although facing challenges post-COVID, is anticipating a rebound with potential upcoming product approvals. Analysts expect its stock to rise 68% as it aims to launch new vaccines, which could positively affect the company’s earnings over time.

Meanwhile, CRISPR Therapeutics has recently received approval for its first product and has the financial strength to continue advancing its pipeline. Its projected stock increase is 87% based on positive trial updates expected soon.

Stocks: NASDAQ:VKTX NASDAQ:MRNA NASDAQ:CRSP NASDAQ:VRTX NYSE:LLY NASDAQ:NVO